News from express scripts A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NYSE:EXPR)

Jul 17, 2014, 07:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

State Governments May Spend $55 Billion on Hepatitis C Medications

 State legislatures will need to find billions in their budgets to purchase costly new hepatitis C therapy, according to a new state-by-state...

Jul 01, 2014, 08:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Names David Queller Senior Vice President, Sales and Account Management

Express Scripts Holding Company (NASDAQ: ESRX) today announced that David Queller will join the company as Senior Vice President, Sales and Account...

Jun 09, 2014, 08:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Top 5 Percent of Opioid Prescribers Write 40 Percent of US Narcotic Prescriptions

 Forty percent of U.S. narcotic prescriptions in 2011-2012 were written by only five percent of opioid prescribers, according to a study...

May 05, 2014, 08:32 ET

Express Scripts to Present at Upcoming Conferences

 Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: - Bank of America...

Apr 29, 2014, 16:02 ET

Express Scripts Announces 1st Quarter Results

 Express Scripts Holding Company (Nasdaq: ESRX) announced 2014 first quarter net income attributable to Express Scripts1 stockholders of $328.3...

Apr 18, 2014, 17:45 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract

The U.S. Department of Defense today awarded Express Scripts (NASDAQ: ESRX) administration of the TRICARE Pharmacy Program, Fourth Generation...

Apr 10, 2014, 09:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Cost Increases Drive Higher Drug Trend for Workers' Compensation

 Significant increases in cost per prescription drove drug trend for workers' compensation payers higher in 2013, according to research...

Apr 09, 2014, 08:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Analysis Reveals First Look at Medication Utilization Trends Among Public Health Insurance Exchange Enrollees

 In a first look at pharmacy trends in Public Health Insurance Exchange plans, use of specialty medications was greater among Exchange...

Apr 08, 2014, 08:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

U.S. Spending on Hepatitis C Medications to Skyrocket 1,800 Percent by 2016

Expensive treatments for broad patient populations are driving unprecedented growth in U.S. spending on specialty drugs to treat complex conditions...

Mar 20, 2014, 11:30 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Named as a 2014 World's Most Ethical Company by the Ethisphere Institute

Express Scripts (NASDAQ: ESRX) announced today that it has been recognized by the Ethisphere Institute, an independent center of research promoting...

Mar 12, 2014, 07:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

ADHD Medication Use Continues to Climb, Biggest Gains Seen Among Adults

The number of Americans who use medication to treat Attention Deficit Hyperactivity Disorder (ADHD) rose 36 percent in 5 years, totaling more than...

Feb 27, 2014, 08:30 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Workers' Compensation Solution Helps Payers Address the Rising Cost of Physician Dispensing

Medications dispensed through a physician's office are often repackaged and priced as much as 60 to 300 percent higher than an identical drug...

Feb 24, 2014, 09:13 ET

Express Scripts to Present at Upcoming Conferences

 Express Scripts (Nasdaq: ESRX) announced that it will present at the following conferences: - Cowen and Company 34th Annual...

Feb 20, 2014, 16:48 ET

Express Scripts Announces Record 4th Quarter Adjusted EPS of $1.12; Reported EPS of $0.64

 Express Scripts Holding Company (Nasdaq: ESRX) announced 2013 fourth quarter and full year net income from continuing operations attributable...

Feb 10, 2014, 08:30 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Unveils Industry-Leading Medicare Star Ratings Modeling Dashboard for Health Plans

 Presenting today at the Institute for International Research 11th Annual Medicare Congress, Express Scripts (NASDAQ: ESRX) is introducing a...

Jan 28, 2014, 16:01 ET
Tim Wentworth Named President of Express Scripts. (PRNewsFoto/Express Scripts)

Tim Wentworth Named President of Express Scripts

Express Scripts Holding Company (NASDAQ: ESRX) today appointed Tim Wentworth as President. He will have management responsibility for all...

Jan 14, 2014, 08:00 ET
Express Scripts, St. Louis, Missouri. (PRNewsFoto/Express Scripts)

Express Scripts Names Cathy R. Smith Chief Financial Officer

 Express Scripts Holding Company (NASDAQ: ESRX) today announced that Cathy R. Smith will join the company as Executive Vice President and...

Jan 03, 2014, 08:20 ET

Express Scripts to Present at the J.P. Morgan Healthcare Conference

Express Scripts Holding Company (Nasdaq: ESRX) announced that it will present at the J.P. Morgan Healthcare Conference on January 15, 2014 at 8:00...

Dec 20, 2013, 08:12 ET

Express Scripts to Webcast Investor Day Meeting

Express Scripts Holding Company (Nasdaq: ESRX) announced today its intention to release its fourth quarter earnings and 2014 earnings guidance on...

Dec 10, 2013, 08:32 ET

Express Scripts Announces Accelerated Share Repurchase Transaction

 Express Scripts Holding Company (Nasdaq: ESRX) announced that it has entered into an accelerated share repurchase, or ASR, transaction with...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
ReportBuyer
Investor-Edge